Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the standard treatment (surgery followed by either radioactive iodine or observation) is effective. Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers have prolonged progression-free survival, but these drugs are not curative and therefore are reserved for patients with progressive or symptomatic disease

Thyroid cancer / Cabanillas, Maria E; Mcfadden, David G.; Durante, Cosimo. - In: THE LANCET. - ISSN 0140-6736. - STAMPA. - 388:10061(2016), pp. 2783-2795. [10.1016/S0140-6736(16)30172-6]

Thyroid cancer

DURANTE, COSIMO
2016

Abstract

Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the standard treatment (surgery followed by either radioactive iodine or observation) is effective. Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers have prolonged progression-free survival, but these drugs are not curative and therefore are reserved for patients with progressive or symptomatic disease
2016
thyroid cancer
01 Pubblicazione su rivista::01a Articolo in rivista
Thyroid cancer / Cabanillas, Maria E; Mcfadden, David G.; Durante, Cosimo. - In: THE LANCET. - ISSN 0140-6736. - STAMPA. - 388:10061(2016), pp. 2783-2795. [10.1016/S0140-6736(16)30172-6]
File allegati a questo prodotto
File Dimensione Formato  
Cabanillas_Thyroid cancer_2016.pdf

accesso aperto

Note: Articolo principale
Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 716.11 kB
Formato Adobe PDF
716.11 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/908822
Citazioni
  • ???jsp.display-item.citation.pmc??? 552
  • Scopus 992
  • ???jsp.display-item.citation.isi??? 920
social impact